We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HOV:NYSEHovnanian Enterprises, Inc. Analysis

Data as of 2026-06-13 - not real-time

$120.72

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: The stock is trading above its short‑term moving averages but remains under the long‑term average, indicating a short‑term bounce within a broader downtrend. Momentum indicators show moderate strength (RSI in the low‑60s) and a bullish MACD crossover, yet the overall trend is flagged as bearish and price volatility is exceptionally high, with a 30‑day swing approaching 80%. Volume has been tapering, suggesting waning buying pressure.
Fundamental backdrop: Revenue is contracting modestly year‑over‑year and profit margins sit at single‑digit levels, while the price‑to‑earnings multiple is well above market averages, pointing to an overvalued valuation. Debt levels are substantial relative to equity, and cash generation barely covers debt service, leaving little room for dividend sustainability. Recent quarterly results did beat internal targets and showed incremental margin improvement, but the consensus target price sits markedly lower than the current market price, implying a sizable downside risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish longer‑term trend despite short‑term bullish MACD
  • Elevated volatility and decreasing volume
  • Current price well above analyst target

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Improving margins reported in the latest quarter
  • High debt‑to‑equity ratio limiting financial flexibility
  • Potential for price correction toward target levels

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Cyclical recovery in residential construction could lift revenues
  • Management's execution track record and recent margin gains
  • Undervalued balance‑sheet assets relative to book value

Key Metrics & Analysis

Financial Health

Revenue Growth-2.70%
Profit Margin1.25%
P/E Ratio33.4
ROE4.40%
ROA1.96%
Debt/Equity130.14
P/B Ratio1.0
Op. Cash Flow$295.6M
Free Cash Flow$41.3M

Technical Analysis

TrendBearish
RSI60.5
Support$91.52
Resistance$125.99
MA 20$109.27
MA 50$110.16
MA 200$118.49
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Target Price$74.00
Upside/Downside-38.70%
GradeOvervalued
TypeValue

Risk Assessment

Beta1.86
Volatility79.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.